Ser Educacional (SEER3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
27 Dec, 2025Executive summary
Achieved strong double-digit growth in adjusted EBITDA and net operating cash generation, with adjusted EBITDA up 18.3% to R$122.5 million and net operational cash generation rising 206.4% to R$50.1 million in 4Q24, enabling a 9% reduction in net debt and resumption of dividend payments after three years.
Significant expansion in student base, especially in hybrid and health-related courses, with hybrid undergraduate intake up 16.7% and digital undergraduate intake up 9.2% year-over-year.
Operational optimization since 2022 has driven margin expansion, improved cash flow, and reduced financial leverage for the eighth consecutive quarter.
Adjusted net income more than doubled year-over-year in 4Q24 to R$36.3 million, with net margin up 3.2 p.p.
Dividend distribution of R$19.6 million (BRL 0.15 per share) approved for May 2025, pending shareholder approval.
Financial highlights
Net revenue increased 8.7% year-over-year to R$523.8 million in 4Q24; full-year revenue up 8.2%.
Adjusted EBITDA margin expanded to 23.4% from 21.5% in 4Q23.
Net operating cash generation increased by more than 200% compared to the same quarter last year.
Net debt reduced by 9.3% to R$718.7 million; net debt/adjusted EBITDA improved to 1.64x.
CAPEX increased year-over-year, with 4Q24 at R$27.4 million, focused on health labs, licenses, and campus upgrades.
Outlook and guidance
Entering 2025 with a larger number of medical student places, expected to be a key driver of future results.
Conservative expansion strategy focused on high-demand courses (health, law), accreditation of new medical courses, and participation in Mais Médicos.
Continued focus on operational efficiency, cash generation, and further debt reduction, with plans for greater dividend distribution from 2026.
New units opened in Bragança, Manaus, and Florianópolis in 1H25, aligned with focus on health and law courses.
Strategic initiatives target academic quality improvement, higher margins, and leverage reduction.
Latest events from Ser Educacional
- Adjusted net income rose 8.5% to R$46.2M, with strong hybrid and health course growth.SEER3
Q2 20242 Feb 2026 - Revenue and EBITDA surged as leverage fell, led by health and medicine course expansion.SEER3
Q3 202414 Jan 2026 - Record profitability in 1Q25 fueled by hybrid and medical education growth and margin gains.SEER3
Q1 202526 Nov 2025 - Net income up 66.4%, hybrid enrollment up 13.8%, and net debt/EBITDA down to 1.24x.SEER3
Q2 202523 Nov 2025 - Adjusted net income up 24.5% and net debt down 21.9% on Hybrid Learning and margin gains.SEER3
Q3 202517 Nov 2025 - Hybrid learning growth and operational gains drove profitability and lower net debt in Q1 2024.SEER3
Q1 20243 Jun 2025